INSM
Insmed Incorporated
NASDAQ · USHealthcareBiotechnology
$107.02-1.20%
Price as of Jul 20, 2026
INSM capital
Insmed Incorporated capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 1.06x
- Net debt / equity
- 0.24x
- Debt / assets
- 0.36x
- Debt / EBITDA
- -0.69x
- Net debt / EBITDA
- -0.15x
Liquidity & coverage
- Current ratio
- 4.47x
- Quick ratio
- 4.10x
- Cash ratio
- 3.39x
- Interest coverage
- -13.72x
- EBITDA / interest
- -13.14x
- Working capital
- $1.3B
Cash & dividend
- FCF / debt
- -1.27x
- Cash flow / debt
- -1.20x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.